1-1 of 1
Francisco de Valle
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunochemotherapy with Rituximab Improves Molecular CR Rate and Outcome In CD20+ B-Lineage Standard and High Risk Patients; Results of 263 CD20+ Patients Studied Prospectively In GMALL Study 07/2003

Dieter Hoelzer, MD, Andreas Huettmann, MD, Felix Kaul, Sebastian Irmer, Nadja Jaekel, Martin Mohren, Thomas Lipp, Knut Wedelin, Francisco de Valle, Mathias Schmid, MD, Eckhard Thiel, Prof., Dr., Dr., h.c., Monika Brueggemann, Michael Kneba, MD, PhD, Nicola Goekbuget, MD
Journal: Blood
Blood (2010) 116 (21): 170.
https://doi.org/10.1182/blood.V116.21.170.170
Published: 2010